amylmetacresol
Small moleculeexperimental
Amylmetacresol (AMC) is an antiseptic used to treat infections of the mouth and throat. It is used as an active pharmaceutical ingredient in Strepsils, Cēpacol, Gorpils, Cofsils and Lorsept throat lozenges, typically in combination with dichlorobenzyl alcohol, another antiseptic. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 17, 2019 (NCT03944655)
Timeline
No events for the selected filters.
Mechanism of action
- Unspecified targetOTHER
Unknown
Amylmetacresol has antivial, antibactericidal, and local anesthetic properties. It is one of the two core active ingredients of throat lozenges (amylmetacresol 0.6 mg and 2,4-dichlorobenzyl alcohol 1.2mg)
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCc1ccc(C)cc1O- Mol. weight
- 178.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAmylmetacresol ↗
- ChEMBLCHEMBL1512677 ↗
Also known as
- amylmetacresol
- amylmetacresol
- throaties
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06220175 | N/A | Mar 1, 2024 | Carol Davila University of Medicine and Pharmacy |
| NCT03944655 | N/A | Jan 17, 2019 | University of Malaya |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Carol Davila University of Medicine and Pharmacy | Academic/Hospital | 1 | 1 | 1 | 2024 |
| University of Malaya | Academic/Hospital | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1